AstraZeneca says antibody treatment failed in preventing Covid-19 in exposed patients

AZD7442 reduced the risk of developing symptomatic Covid-19 by 33% compared to a placebo

Comments

Popular posts from this blog

‘No difference between Congress, PFI’: Karnataka BJP

2 Mangaluru businessmen in Saudi to fly 167 home